Justice Forum Fanatic

Topics: 117 Posts: 2,324
| | 05/14/07 - 09:42 AM  
 
   
 
|   #1 |
We know that Gleevec is a front-line drug to treat CML. I recently found that there are new options pertaining to this same approach: Sprycel: the brand name for dasatinib, a tyrosine kinase inhibitor, which is approved to treat CML for patients who do not respond to Gleevec. Tasigna is in clinical trials
___________________ Don't live in a town where there are no doctors
|
| doyoudig Forum Guru
Topics: 144 Posts: 613
| | 05/14/07 - 03:53 PM  
 
   
 
|   #2 |
How about going straight to BM Transplanation?, It is prefeferd Rx of a Domor is available or do we alwasy start them of on Tyrosine K -'s
|
| doc_clotaire Forum Guru

Topics: 159 Posts: 1,274
| | 05/14/07 - 04:00 PM  
 
   
 
|   #3 |
If the patient is less than 60 yo and have available donor --------the BMT is the best option IF not ...... than you can go with IMITANIB (Gleevec ) I never heard about Dasatinib Justice . Have it shown better than IMITANIB or what ?
___________________ The elevator to succes is broke ,you must take the stairs
|
|
| |
| | | |